Filing Details
- Accession Number:
- 0001209191-14-053566
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-08-19 20:27:01
- Reporting Period:
- 2014-08-18
- Filing Date:
- 2014-08-19
- Accepted Time:
- 2014-08-19 19:27:01
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1493566 | Otonomy Inc. | OTIC | Pharmaceutical Preparations (2834) | 262590070 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1376355 | Jay Lichter | C/O Avalon Ventures 1134 Kline Street La Jolla CA 92037 | Yes | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-08-18 | 740,057 | $0.00 | 748,589 | No | 4 | C | Indirect | See footnote |
| Common Stock | Acquisiton | 2014-08-18 | 660,580 | $0.00 | 1,409,169 | No | 4 | C | Indirect | See footnote |
| Common Stock | Acquisiton | 2014-08-18 | 91,011 | $8.79 | 1,500,180 | No | 4 | X | Indirect | See footnotes |
| Common Stock | Disposition | 2014-08-18 | 50,001 | $16.00 | 1,450,179 | No | 4 | S | Indirect | See footnotes |
| Common Stock | Acquisiton | 2014-08-18 | 705,598 | $0.00 | 705,598 | No | 4 | C | Indirect | See footnote |
| Common Stock | Acquisiton | 2014-08-18 | 109,375 | $16.00 | 814,973 | No | 4 | P | Indirect | See footnotes |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | C | Indirect | See footnote |
| No | 4 | C | Indirect | See footnote |
| No | 4 | X | Indirect | See footnotes |
| No | 4 | S | Indirect | See footnotes |
| No | 4 | C | Indirect | See footnote |
| No | 4 | P | Indirect | See footnotes |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Series A Preferred Stock | Disposition | 2014-08-18 | 337,432 | $0.00 | 740,057 | $0.00 |
| Common Stock | Series B Preferred Stock | Disposition | 2014-08-18 | 175,889 | $0.00 | 175,889 | $0.00 |
| Common Stock | Series C Preferred Stock | Disposition | 2014-08-18 | 484,691 | $0.00 | 484,691 | $0.00 |
| Common Stock | Series C Preferred Stock | Disposition | 2014-08-18 | 568,828 | $0.00 | 568,828 | $0.00 |
| Common Stock | Series D Preferred Stock | Disposition | 2014-08-18 | 136,770 | $0.00 | 136,770 | $0.00 |
| Series A Preferred Stock | Series A Preferred Stock Warrant (right to buy) | Disposition | 2014-08-18 | 6,432 | $0.00 | 6,432 | $31.09 |
| Common Stock | Common Stock Warrant (right to buy) | Acquisiton | 2014-08-18 | 14,106 | $0.00 | 14,106 | $14.18 |
| Series A Preferred Stock | Series A Preferred Stock Warrant (right to buy) | Disposition | 2014-08-18 | 6,432 | $0.00 | 6,432 | $31.09 |
| Common Stock | Common Stock Warrant (right to buy) | Acquisiton | 2014-08-18 | 14,106 | $0.00 | 14,106 | $14.18 |
| Series A Preferred Stock | Series A Preferred Stock Warrant (right to buy) | Disposition | 2014-08-18 | 6,432 | $0.00 | 6,432 | $31.09 |
| Common Stock | Common Stock Warrant (right to buy) | Acquisiton | 2014-08-18 | 14,106 | $0.00 | 14,106 | $14.18 |
| Series A Preferred Stock | Series A Preferred Stock Warrant (right to buy) | Disposition | 2014-08-18 | 6,432 | $0.00 | 6,432 | $31.09 |
| Common Stock | Common Stock Warrant (right to buy) | Acquisiton | 2014-08-18 | 14,106 | $0.00 | 14,106 | $14.18 |
| Series A Preferred Stock | Series A Preferred Stock Warrant (right to buy) | Disposition | 2014-08-18 | 6,432 | $0.00 | 6,432 | $31.09 |
| Common Stock | Common Stock Warrant (right to buy) | Acquisiton | 2014-08-18 | 14,106 | $0.00 | 14,106 | $14.18 |
| Series A Preferred Stock | Series A Preferred Stock Warrant (right to buy) | Disposition | 2014-08-18 | 6,432 | $0.00 | 6,432 | $31.09 |
| Common Stock | Common Stock Warrant (right to buy) | Acquisiton | 2014-08-18 | 14,106 | $0.00 | 14,106 | $14.18 |
| Series A Preferred Stock | Series A Preferred Stock Warrant (right to buy) | Disposition | 2014-08-18 | 6,432 | $0.00 | 6,432 | $31.09 |
| Common Stock | Common Stock Warrant (right to buy) | Acquisiton | 2014-08-18 | 14,106 | $0.00 | 14,106 | $14.18 |
| Series A Preferred Stock | Series A Preferred Stock Warrant (right to buy) | Disposition | 2014-08-18 | 6,432 | $0.00 | 6,432 | $31.09 |
| Common Stock | Common Stock Warrant (right to buy) | Acquisiton | 2014-08-18 | 14,106 | $0.00 | 14,106 | $14.18 |
| Series A Preferred Stock | Series A Preferred Stock Warrant (right to buy) | Disposition | 2014-08-18 | 6,432 | $0.00 | 6,432 | $31.09 |
| Common Stock | Common Stock Warrant (right to buy) | Acquisiton | 2014-08-18 | 14,106 | $0.00 | 14,106 | $14.18 |
| Series A Preferred Stock | Series A Preferred Stock Warrant (right to buy) | Disposition | 2014-08-18 | 6,432 | $0.00 | 6,432 | $31.09 |
| Common Stock | Common Stock Warrant (right to buy) | Acquisiton | 2014-08-18 | 14,106 | $0.00 | 14,106 | $14.18 |
| Series C Preferred Stock | Series C Preferred Stock Warrant (right to buy) | Disposition | 2014-08-18 | 91,011 | $0.00 | 91,011 | $8.79 |
| Common Stock | Common Stock Warrant (right to buy) | Acquisiton | 2014-08-18 | 91,011 | $0.00 | 91,011 | $8.79 |
| Common Stock | Common Stock Warrant (right to buy) | Disposition | 2014-08-18 | 91,011 | $0.00 | 91,011 | $8.79 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | C | Indirect | ||
| 0 | No | 4 | C | Indirect | ||
| 0 | No | 4 | C | Indirect | ||
| 0 | No | 4 | C | Indirect | ||
| 0 | No | 4 | C | Indirect | ||
| 0 | 2018-11-04 | No | 4 | C | Indirect | |
| 14,106 | 2018-11-04 | No | 4 | C | Indirect | |
| 0 | 2018-12-08 | No | 4 | C | Indirect | |
| 14,106 | 2018-12-08 | No | 4 | C | Indirect | |
| 0 | 2019-01-14 | No | 4 | C | Indirect | |
| 14,106 | 2019-01-14 | No | 4 | C | Indirect | |
| 0 | 2019-04-13 | No | 4 | C | Indirect | |
| 14,106 | 2019-04-13 | No | 4 | C | Indirect | |
| 0 | 2019-07-01 | No | 4 | C | Indirect | |
| 14,106 | 2019-07-01 | No | 4 | C | Indirect | |
| 0 | 2019-10-08 | No | 4 | C | Indirect | |
| 14,106 | 2019-10-08 | No | 4 | C | Indirect | |
| 0 | 2019-12-15 | No | 4 | C | Indirect | |
| 14,106 | 2019-12-15 | No | 4 | C | Indirect | |
| 0 | 2020-01-22 | No | 4 | C | Indirect | |
| 14,106 | 2020-01-22 | No | 4 | C | Indirect | |
| 0 | 2020-04-01 | No | 4 | C | Indirect | |
| 14,106 | 2020-04-01 | No | 4 | C | Indirect | |
| 0 | 2020-05-28 | No | 4 | C | Indirect | |
| 14,106 | 2020-05-28 | No | 4 | C | Indirect | |
| 0 | 2014-08-18 | No | 4 | C | Indirect | |
| 91,011 | 2014-08-18 | No | 4 | C | Indirect | |
| 0 | 2014-08-18 | No | 4 | X | Indirect |
Footnotes
- The reported securities are held of record by Avalon Ventures VIII, L.P. ("Avalon VIII LP"). The Reporting Person is a managing director of Avalon Ventures VIII GP, LLC ("Avalon VIII GP"), the general partner of Avalon VIII LP, and disclaims beneficial ownership of the securities held by Avalon VIII LP except to the extenet of any pecuniary interest therein.
- The Series A Convertible Preferred Stock automatically converted into Common Stock on a 2.193204365 to one basis immediately prior to the completion of the Issuer's initial public offering of common stock and had no expiration date.
- Each of the Series B Convertible Preferred Stock, Series C Convertible Preferred Stock and Series D Convertible Preferred Stock automatically converted into Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of common stock and had no expiration date.
- The reported securities are held of record by Avalon Ventures X, L.P. ("Avalon X LP"). The Reporting Person is a managing director of Avalon Ventures X GP, LLC ("Avalon X GP"), the general partner of Avalon X LP, and disclaims beneficial ownership of the securities held by Avalon X LP except to the extenet of any pecuniary interest therein.
- The warrants are immediately exercisable.
- The Series C Preferred Stock Warrants automatically converted into Common Stock Warrants on a one to one basis immediately prior to the completion of the Issuer's initial public offering of common stock.
- Avalon VIII LP exercised the warrants to purchase 91,011 shares of Issuer Common Stock for $8.79 per share immediately prior to the completion of the Issuer's initial public offering of common stock. Avalon VIII LP paid the exercise price on a cashless basis, resulting in Issuer's withholding of 50,001 of the warrant shares to pay the exercise price and issuing to Avalon VIII LP the remaining 41,010 shares. The shares issued pursuant to such exercise remain subject to a 180-day lock-up restriction.
- Avalon X LP purchased 109,375 shares of Issuer Common Stock in the Issuer's initial public offering.
Billionaire Hedge Funds
